Loading clinical trials...

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT02543918

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

The purpose of this study is to compare the body's immune response when vaccines are given alone versus when vaccines are given along with the study drug called ixekizumab. The vaccines protect agains...

Lead sponsor: Eli Lilly and Company•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

RECRUITINGNA

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 6, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment84

Start dateSep 2015

Last updatedJan 6, 2017

Condition

Healthy

Locations shown

Covance

Daytona Beach, Florida

Covance

Evansville, Indiana

Covance

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 6, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

Cytapheresis of Volunteer Donors

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Sodium vs Potassium Education to Improve Vascular Health

Trial snapshot

Condition

Locations shown

For caregivers